about
TPGS-chitosan cross-linked targeted nanoparticles for effective brain cancer therapy.Transition from passive to active targeting of oral insulin nanomedicines: enhancement in bioavailability and glycemic control in diabetes.Bioadhesive micelles of d-α-tocopherol polyethylene glycol succinate 1000: Synergism of chitosan and transferrin in targeted drug delivery.Upconversion nanotheranostics: emerging designs for integration of diagnosis and therapyDNA biodots based targeted theranostic nanomedicine for the imaging and treatment of non-small cell lung cancerNanotheranostics: Emerging Strategies for Early Diagnosis and Therapy of Brain CancerWhat are the unexplored facts about nanomicelles formed from docetaxel clinical injection?
P50
Q36295931-07F31462-62A7-4A9F-8917-82241E3FD4A9Q38832783-4D3E11FA-5EA8-4056-A3D4-A6A042B0FD29Q48340206-16AA997B-0F63-4A36-8FE6-3804F184051CQ89378120-A8EF3C5F-8F73-4226-9ACE-147E86A0525EQ89713199-2F52ECFC-47A9-41BA-AE35-05FAA1A20FF2Q89764975-109A7347-892A-4F1B-9AFD-97A4B6D94CE4Q90918148-525D26A9-ACD8-4B96-8779-F4987AE7271E
P50
description
researcher
@en
wetenschapper
@nl
name
Abhishesh Kumar Mehata
@en
Abhishesh Kumar Mehata
@nl
type
label
Abhishesh Kumar Mehata
@en
Abhishesh Kumar Mehata
@nl
prefLabel
Abhishesh Kumar Mehata
@en
Abhishesh Kumar Mehata
@nl
P31
P496
0000-0003-1392-5849